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Abstract
Background: In Puerto Rico, relative to the United States, a disparity exists in detecting oral precancers and early
cancers. To identify factors leading to the deficit in early detection, we obtained the perspectives of San Juan
healthcare practitioners whose practice could be involved in the detection of such oral lesions.
Methods: Key informant (KI) interviews were conducted with ten clinicians practicing in or around San Juan,
Puerto Rico. We then triangulated our KI interview findings with other data sources, including recent literature on
oral cancer detection from various geographic areas, current curricula at the University of Puerto Rico Schools of
Medicine and Dental Medicine, as well as local health insurance regulations.
Results: Key informant-identified factors that likely contribute to the detection deficit include: many practitioners
are deficient in knowledge regarding oral cancer and precancer; oral cancer screening examinations are limited
regarding which patients receive them and the elements included. In Puerto Rico, specialists generally perform oral
biopsies, and patient referral can be delayed by various factors, including government-subsidized health insurance,
often referred to as Reforma. Reforma-based issues include often inadequate clinician knowledge regarding
Reforma requirements/provisions, diagnostic delays related to Reforma bureaucracy, and among primary physicians,
a perceived financial disincentive in referring Reforma patients.
Conclusions: Addressing these issues may be useful in reducing the deficit in detecting oral precancers and early
oral cancer in Puerto Rico.
Background
Worldwide in 2008, there were an estimated 263,000
new cases of and 127,000 deaths attributed to cancer of
the lip and oral cavity (ICD-10 C00-C08) [1]. Oral can-
cer incidence rates for Puerto Rico are among the high-
est in the Western Hemisphere, particularly among
males for whom age-adjusted rates (world, all ages
included) were an estimated 8.0/100,000 in 2008 [2].
Recently, Suarez, et al. reported that during the period
1998-2002, age-standardized incidence rates for oral and
pharyngeal cancer (C00-C14) increased in Puerto Rico
for both males and females [3].
Most cancers of the oral cavity and lip are squamous
cell carcinomas, which often arise from red and/or
white precursor lesions presenting on the surface
mucosa [4-7]. It is generally agreed that such lesions
should be biopsied and evaluated histopathologically;
however, oral precancers and early cancers are often
asymptomatic and can go undetected in the absence of
a careful oral examination [4,5,8,9]. In the case of pre-
malignant lesions, a biopsy and histopathologic diagno-
sis provide information as to how closely a lesion
should be followed and whether treatment should be
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detection of in situ and early invasive oral cancers is
important because 5-year survival rates are notably
higher for persons diagnosed with early, relative to late,
stage disease [10,11]. Further, oral cancer patients with
early-stage disease often require less radical cancer-
directed treatment, suffer fewer associated sequellae,
and have a better health-related quality of life than cases
diagnosed with late-stage disease [12,13].
In previous reports we identified a significant disparity
in the biopsying of a) potentially precancerous oral
lesions and b) in situ oral cancers in Puerto Rico relative
to the United States [14,15]. Our findings suggest that
Puerto Rico residents with intraoral lesions suspicious
for oral cancer or precancer are most likely to be biop-
sied only after developing an invasive cancer and there-
fore, are not receiving the benefits of early detection.
In order to meaningfully address shortfalls in the
detection of oral precancer and early-stage cancer in
Puerto Rico, it is important to first consider the poten-
tially diverse perspectives of healthcare practitioners on
the Island in terms of their knowledge, attitudes/beliefs
and practices related to oral precancer and early cancer
diagnosis [14,15]. Toward that aim, key informant (KI)
interviews were conducted with a spectrum of health-
care professionals whose practices, in or around San
Juan, Puerto Rico, could be involved in the detection of
oral precancer and early cancer. We then triangulated
our KI interview findings with other data sources,
including recent literature on oral cancer detection from
various geographic areas, current curricula at the Uni-
versity of Puerto Rico (UPR) Schools of Medicine and
Dental Medicine, as well as local health insurance
regulations.
Methods
The study was approved by the Institutional Review
Boards of the UPR Medical Sciences Campus and New
York University.
The purposive selection of key informants was cen-
tered on the need to obtain multiple perspectives on the
research domains and to cover the range of healthcare
practitioners who could be involved in the detection of
oral precancer and early cancers. Healthcare practi-
tioners selected for participation in the KI interviews
included general dentists (GD), primary care physicians
(PCP), otolaryngologists (ENT), oral surgeons (OS), and
dental assistants/hygienists (DAH). Our sample was lim-
ited to practitioners who practiced in or around the San
Juan Metropolitan Area, i.e., Old San Juan, Santurce,
Hato Rey, Río Piedras, Caimito, Cupey, Guaynabo, Baya-
món, Cataño, Carolina, and Trujillo Alto.
Recruitment of KIs was carried out by one of the
investigators (AEB) in consultation with other members
of the research team as well as with local dental, medi-
cal, and dental hygiene societies. Initially, male and
female practitioners who met the inclusion criteria and
represented a range in terms of years in practice, health-
care role, and practice profiles were identified. From
among the identified clinicians, potential KIs were then
purposively selected to provide both the predetermined
number of participants and multiple perspectives on the
topics of interest. Potential KIs were contacted in a sys-
tematic fashion by AEB, invited to participate, and for
those who agreed, an appointment scheduled. The pro-
cess continued until the required number of practi-
tioners, by type, was achieved. Each participant received
a $250 honorarium for the time required to complete
the interview.
Interview Guide
KI interviews utilize a semi-structured interview guide
which, while having a specific organization and flow,
permits flexibility to obtain open-ended responses and
to follow-up with probes and additional questions on
issues initiated by respondents. The interview guide was
created with input from a panel of eight study personnel
whose expertise and professional backgrounds included
oral healthcare, oral cancer, public health, cultural
anthropology, and qualitative research methodology.
The guide was developed in English, translated into
Spanish, and corroborated for linguistic, cultural, and
social intricacies pertinent to Puerto Rico. The guide
was then reviewed and modifications suggested by a
JAPICO Community Board (Junta Asesora para la Pre-
vención e Investigación de Cancer Oral de Puerto Rico,
or Advisory Council for the Prevention and Research
into Oral Cancer in Puerto Rico), which was established
at the UPR Medical Sciences Campus as part of an oral
cancer center grant [16]. The interview guide was
further refined in terms of language and comprehension
by pretesting the instrument with three healthcare pro-
fessionals (OS, ENT, DAH) [17,18]. The final guide con-
sisted of sequence questions designed to elicit detailed
information, while associated probing questions allowed
informants to elaborate on each of their responses. The
guide included questions relating to professional and
continuing education, the impact of health insurance on
health-seeking and care, the performance of oral cancer
examinations and oral biopsies as well as other factors
that could be related to the observed deficit in early oral
cancer diagnosis.
Key Informant Interview Process
All health professionals were interviewed in their offices
with the exception of one individual who came to the
UPR Medical Sciences Campus for that purpose. Inter-
views were conducted in Spanish on a one-to-one basis
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experience in qualitative public health research (MS).
The process began with an explanation of the research
objectives, intended uses of the information, and assur-
ances of confidentiality. All participants completed the
consent process by signing a consent form that included
permission to record the interview.
Data Analysis
All KI interview audio files were transcribed, and the
transcriptions verified. The product text was then sent to
the primary analyst, who completed the initial analysis,
including the coding of lists and categories. The process
of analyzing the interview texts began using an inductive
process in which major themes were identified. Themes
and supporting quotes were then reviewed and classified
into inclusive categories. These categories were inte-
grated using codes developed by the main analyst from
the interview instrument. The resulting list of codes was
then used to analyze the interview texts by a deductive
method. Texts that represented the codes were then
quoted in order to sustain or validate findings. The pro-
cess was organized using qualitative analysis (Altas.ti)
software. The categories and supporting texts were
further analyzed; coinciding and complimentary cate-
gories were further integrated into a list of codes.
Codes produced in the initial inductive analysis were
compared to the list of codes from the interview guide
and then organized into broad categories responding to
the study objectives and research questions. The process
of analysis, including quote selection, was performed
first individually by each of the three qualitative
researchers and subsequently by a consensus process
with input from members of the entire research team.
Results
Saturation during the analysis process is indicative of
having a more than adequate study sample size as it sug-
gests that more interviews will not produce new informa-
tion. We experienced saturation in the text analysis as we
reached the transcript for the fourth KI interview, and as
we completed analysis of the tenth and final KI interview,
no new codes or categories were generated.
Ten of the eleven practitioners approached to take
part in the interviews agreed to participate - two pri-
mary care physicians, two general dentists, two ENT
specialists, two oral surgeons, and two dental auxillaries,
i.e., one dental hygienist and one registered expanded-
functions dental assistant. Each participant practiced in
or around the San Juan metro area; there were six male
and four female KIs. All interviews were conducted dur-
ing the period February 1-13, 2008, and each participant
answered all questions. Interview length varied from 45
minutes to approximately two hours.
Professional Background and Practice Characteristics
All informants had practiced exclusively in Puerto Rico.
We purposively selected four practitioners who had
practiced for 9-12 years and six who had practiced for
over 16 years. Each KI treated primarily adults and
reported having previously cared for patients covered by
government health insurance. At the time of the inter-
view, six KIs treated primarily patients with government
insurance, and four served mainly patients with private
insurance coverage.
The current form of government-subsidized health
insurance (GSHI) is termed Puerto Rico Health Reform
(Reforma de Salud de Puerto Rico), or simply Reforma
[ 1 9 ]a n di su t i l i z e dl a r g e l y ,b u tn o te x c l u s i v e l y ,b yp e r -
sons of lower socioeconomic status (SES). At the time
of the interview, most KIs continued to care for patients
from lower SES groups; however, two practitioners no
longer treated patients with Reforma-based GSHI.
Reasons for Delays in the Diagnosis of Oral Diseases
Socioeconomic Status
All KIs felt that socioeconomic status had an impact on
the duration that patients wait prior to seeking care,
with many lower SES patients delaying significant oral
health needs for months or years. Patient factors identi-
fied as contributing to delays in health seeking among
those of lower SES included limited financial resources
and lack of education.
I believe that the lower the educational and socioe-
conomic level [of the population], the more we will
have a negative response [not seeking oral health
care] in relation to what we are talking about [oral
cancer] (OS).
Government-Subsidized Health Insurance (GSHI)
While related to lower SES status, most KIs felt that
GSHI was also detrimental to the provision of adequate
healthcare by making it more difficult and time consum-
ing for patients to receive needed attention, with the
delay largely attributed to “red tape,” i.e., “bureaucratic
complexities.” The topic of GSHI in relation to diagnos-
tic delay is addressed further under the heading of
‘Biopsies.’
Knowledge related to Early Detection
Most participants stated that a major barrier to the diag-
nosis of oral precancer and early cancer is a lack of knowl-
edge regarding early signs and symptoms on the part of
both the lay population and healthcare professionals.
Patients are not reached by trained professionals
with the knowledge or the intuition to suspect a pre-
cancerous lesion; evidently [due to] lack of educa-
tion, lack of knowledge (OS).
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routinely observed by most general practitioners, one
general dentist felt that periodic training on the clinical
presentation of oral precancerous and cancerous lesions
is needed in order to keep the material fresh in the
minds of practitioners.
Perhaps lack of knowledge of a lesion as a [precan-
cerous/cancerous] lesion; I believe that since there is
not more frequent training on oral cancer lesions, if
we do not see and do not know, the less you see,
the less you know (GD).
Professional Training
Most participants could identify some previous profes-
sional training related to oral cancer prevention, identifi-
cation, and treatment, primarily as a component within
a course that dealt with a more comprehensive subject
such as oral diagnosis or oncology.
They did offer something, yes, but not a class on
oral cancer or the diagnosis of oral cancer itself.
They offered oral diagnosis, but not oral cancer
(GD).
Two participants (OS, ENT) stressed the importance
of formal professional education in oral cancer detec-
tion. One ENT expressed the need for more compre-
hensive training in which the theoretical, conceptual
and practical aspects of cancer prevention and identifi-
cation were included in the professional curriculum.
On a more cynical note, one KI felt that some clini-
cians preferred not to be educated on the detection of
oral cancer and precancer.
In many occasions, I believe the lack of knowledge is
not a lack of having been provided the information
during training, but instead that the professional
does not care to be educated in this respect (OS).
Continuing Education (CE)
Only three KIs (OS, DAH, GD) reported having attended
a CE course that directly addressed the topic of oral can-
cer during the preceding three years. Reasons given for
not attending an oral cancer CE course during the past
three years included the lack of offerings and unfavorable
reviews from colleagues who had attended the meetings.
I have not attended, because when I have received
information about these courses, they do not attract
my attention, because it is my understanding that
the speakers of these courses will not offer a high
quality conference (OS).
Oral Cancer Examinations and Early Detection
A number of KIs felt that the current status of early oral
cancer detection in Puerto Rico was problematic.
Honestly, very poor [referring to early oral cancer
d e t e c t i o ni nP u e r t oR i c o ]because realistically, it
[oral cancer] is not discovered as much because peo-
ple [health practitioners] do not perform oral exams
on patients. They do not open their mouths. Some-
times people arrive with something they have had
for months, and no one [checks the mouth] (PCP).
Most participants stated that the healthcare profes-
sional with the greatest responsibility for providing an
oral cancer examination is the general dentist although
some felt that all health professionals should perform
opportunistic oral cancer examinations.
It could be any health professional, be it a physician,
generalist, or specialist related to oral health (OS).
Many of the KIs stated that they had at least some
previous training in conducting oral cancer examina-
tions; however, others (GD, both PSPs) had not.
I do not recall having been taught how to perform
an oral exam in any moment (PCP)
Concern was voiced as to the quality of oral cancer
examinations being conducted.
I think they [clinicians] are far from the reality of per-
forming a good oral soft tissue exam. I don’tk n o wi f
it is due to fear or lack of training, but they are far
from the reality of searching for, or going in search
of, [oral abnormalities] as part of the exam (OS).
Among those KIs who reported having received at least
some training in performing an oral cancer examination,
many reported conducting visual-tactile examinations
(VTE). Based upon the interviews, however, it became
clear that a consistent definition was lacking as to what
constitutes a visual-tactile examination, and only two KIs
(OS, ENT) described a VTE as including visualization
and palpation of the oral cavity, head, and neck. The
majority of KIs emphasized the importance of visualizing
the oral structures during oral cancer examinations, with
less importance placed on the tactile component.
With the caveat that the term “visual-tactile examina-
tion” was self-defined by and not consistent across all
practitioners, three KIs (OS, both ENTs) reported that
they conducted a VTE on all adult patients while four
(OS, PCP, both GDs) reported they performed an oral
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there was a specific patient concern about a possible
abnormality. Two KIs (DAH, PCP) reported they did
not perform VTEs on any patients, and one KI (DAH)
stated that only visual examinations were performed at
her present practice. For those KIs who reported they
would perform a complete VTE only when they consid-
ered the patient to be at high risk, most agreed that the
factors used to determine risk were age (40+), gender
(male), a history of smoking and/or heavy drinking, low
socioeconomic status, and poor hygiene.
I perform them [VTE] mainly on high-risk patients,
drinkers and smokers, but I do not perform them
routinely on all patients (GD).
For most participants, risk assessment was judged to
be a more important element than a tactile examination.
One KI (ENT) felt that the oral cancer CE courses he
attended made the assumption that everyone had a
common knowledge as to what constitutes and how to
perform a thorough VTE.
It was assumed that everyone knew how to perform
a tactile examination with both hands (ENT).
Conversely, one KI (GD) reported a change in practice
toward performing visual and tactile examinations after
attending a hands-on CE course that recommended a
thorough tactile examination and provided the opportu-
nity to learn how to perform it.
One participant recommended that CE credits on the
topic of oral cancer be mandatory for all healthcare pro-
fessionals.
It [oral cancer CE] should be as compulsory as once
were courses for CPR and breastfeeding (GD).
Biopsies
When asked about who should perform oral biopsies,
the general opinion was that such procedures are the
domain of surgeons, i.e., ENTs, oral surgeons.
The oral surgeons and ENTs reported that they routi-
nely perform oral biopsies when they detect a suspicious
lesion.
I can detect a precancerous or cancerous lesion, and
I perform a biopsy immediately during the initial
visit (OS).
On the other hand, general dentists and primary care
physicians reported that they refer patients who require
an oral biopsy to specialists.
If I see a suspicious lesion, I inform the patient that
there is a rare lesion, and I send the patient to the
oral surgeon, because I do not perform biopsies
(GD).
When referring a patient with a suspicious lesion,
practitioners did so with the knowledge that the refer-
ral could result in a delay in obtaining both the biopsy
and subsequent diagnosis. For example, some practi-
tioners acknowledged that delays in diagnosis may
arise due to issues related to coordinating the referral.
Such difficulties were most often described in terms of
government-subsidized health insurance; however, it
was stated that the referral process could also be hin-
dered by other forms of insurance that require pre-
authorization.
If the patient has private insurance that covers ser-
vices, this person will seek treatment directly from
the specialist. This person will go directly to the
ENT or oral surgeon or periodontist; you know, he
will call and get an appointment, has insurance pay
for services and receives a diagnosis. Patients from
health systems such as government insurance and
HMOs have to go through a process of authoriza-
tions (ENT).
On a related note, it was also stated that referrals can
be delayed by a medical office administrator who does
not move the referral documentation ahead in a timely
manner.
There was considerable confusion on the part of some
informants as to GSHI guidelines relating to oral biopsy
referrals, and two informants (PCP and GD) felt that
perceived problems with GSHI often result from a lack
of knowledge on the part of clinicians regarding insur-
ance coverage and how to use it to the advantage of the
patient.
The capitated nature of GSHI applies to many health-
care practitioners in Puerto Rico, but not dentists.
Because referrals made under a capitated system can be
regarded by some practitioners as financial liabilities to
be avoided, a few KIs were concerned that monetary
considerations can arise that influence when and when
not to refer a patient.
Reforma gives great responsibility to primary physi-
cians in making these decisions - limiting or not, his
work capital [capitation payments]. These are really
the conflicts that can be created. But in reality, with-
out biopsies and diagnosis, options for treatment
cannot be provided. Yes, they [the patients] are
affected (PSP).
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patients themselves often delay their biopsy appointment
due to fear of the biopsy, fear of a diagnosis of cancer or
other major disease, or fear of associated costs. For
example, when GSHI payments are lower than the usual
and customary rate, patient out-of-pocket expenses may
create an obstacle to receiving a timely biopsy.
[The general dentists] are going to refer and even if
the oral surgeon accepts Reforma, somehow it ends
up costing [the patient] $100 for the consult (GD).
In order to avoid delays in obtaining a biopsy and
diagnosis, three KIs (GD, OS, DAH) felt that general
dentists, and perhaps primary care physicians, should
receive more training in performing oral biopsies.
Recently-graduated health professionals do not know
how to recognize cancer; second, they do not know
how to perform a biopsy. In other words, for me,
having received training thirty-something years ago
gave us an excuse, but at a moment when cancer is
so important and [there is] so much concern and
leagues against cancer and battles against cancer, it
is a concern that a youngster [young health profes-
sional] does not know how to perform a biopsy
(GD).
Discussion
Recent findings provide strong evidence that in Puerto
Rico, oral lesions suspicious for precancer or early can-
cer are most likely to be biopsied only after developing
an invasive cancer [14,15]. Such findings are important
because delays in oral cancer diagnosis can have sub-
stantial consequences in terms of the treatment
required, quality of life, and long-term survival.
In order to obtain insight into the factors that contri-
bute to the apparent delay in biopsying and diagnosing
lesions suspicious for early oral cancer and precancer,
qualitative data were obtained using KI interviews with
healthcare practitioners whose practice could be
involved in the detection of oral precancer and early
cancers. By design, the group of KIs covered a range of
healthcare practitioners who practiced in the Greater
San Juan Metropolitan Area and could offer diverse per-
spectives on the research topics of interest. During these
interviews, the key informants identified three broad
areas they believed account for a substantial portion of
the apparent delays, i.e., the healthcare-seeking public,
healthcare practitioners, and the insurance system. The
current paper focuses largely on the latter two areas;
subsequent papers, based on focus groups comprised of
lay individuals, will explore perspectives of the health-
care-seeking public.
Reasons for Diagnostic Delays
Socioeconomic Status of the Health-seeking Public (SES)
Most of the health practitioners felt that the delay in
oral cancer diagnosis was inversely related to level of
patient socioeconomic status. However, while there is
good evidence that low, relative to high, socioeconomic
status is associated with an increased risk of oral cancer
[20], the impact of SES on diagnostic delay has received
little attention and is currently poorly understood for
oral [21] and many other cancers [22]. Whether or not
SES independently impacts oral cancer diagnostic delay
in Puerto Rico, lower socioeconomic status is clearly
related to GSHI, another factor identified by participants
as an important predictor of delays in the detection of
oral precancers and early cancers.
Government-Subsidized Health Insurance (GSHI)
GSHI, the expanded Medicaid program for Puerto Rico,
or Reforma, is a managed healthcare program that was
enacted in 1993 and phased in by geographical area
beginning in 1994 [23,24]. In general, Reforma covers
Puerto Rico residents who are underinsured earning up
to 200% of the local poverty level; public sector employ-
ees, veterans and their families; persons eligible for
Medicaid, and Medicare recipients without complete
coverage [25,26]. Reforma currently covers an estimated
40% of Island residents [23]. Although healthcare, as
provided through Reforma, is largely a capitated pro-
gram, the provision of dental services by dentists and
dental specialists is on a fee-for-service basis [24]. Our
KI interviews revealed that many practitioners are not
clear on various Reforma guidelines and requirements,
with much of the confusion centering on biopsy
referrals.
Knowledge related to oral precancer and early cancer
detection
Professional Training
Some KIs reported that deficits in the detection of oral
precancers and early cancers were due, at least in part,
to a limited background knowledge of oral cancer and
its signs and symptoms among many clinicians on the
Island, a finding echoed in previous studies involving
physicians and dentists in other geographic areas
[27-29]. The consistency in findings across studies, in
addition to the perceived frontline status of dentists and
other healthcare practitioners in the identification of
oral precancer and early cancer, argue that both dental
and medical students receive a strong background in
oral cancer signs, symptoms, and clinical presentation
during their professional training.
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at least nine years prior to being interviewed and there-
fore, with the exception of the specialist participants,
may have had less oral cancer training than more recent
dental and medical school graduates. This is notable in
that previous studies conducted on the United States
mainland suggest that time since graduation from dental
or medical school is inversely related to oral cancer
knowledge [30-32].
Most dentists and primary care physicians currently
practicing in Puerto Rico received their professional
health training on the Island. A recent review of the
four-year curriculum at the UPR School of Dental Medi-
cine revealed that there are currently ten courses in the
undergraduate dental curriculum that include informa-
tion on oral cancer and precancer, e.g., oral diagnosis
and treatment planning, oral pathology (C. Krespo, per-
sonal communication). At the UPR Medical School,
courses that cover oral cancer are also integrated into
the curriculum. While it is beyond the scope of the cur-
rent study to evaluate the effectiveness of medical and
dental school curricula in Puerto Rico as regards oral
cancer, previous studies on the United States mainland
have recommended that medical and dental schools in
general increase their training on the topic of oral can-
cer [31,33-36]. Possible programmatic additions to the
medical and dental curricula in Puerto Rico, including
those of applicable residencies, could include require-
ments for demonstrating skills in a) knowing risk factors
for the disease, b) identifying oral lesions suspicious for
precancer and early cancer, and c) performing oral can-
cer examinations [37,38]. Licensure examinations could
also be expanded to include testing of the same skills.
Continuing Education (CE)
Evolving information on oral cancer risk factors, exami-
nation techniques, and changing trends in cancer inci-
dence and mortality highlights the need for clinicians to
periodically update their knowledge on oral cancer-
related topics. Nevertheless, based upon responses of
health practitioners involved in our interviews, oral can-
cer CE has not been a priority for the majority of parti-
cipants. Similarly, studies conducted on the United
States mainland have revealed that a sizable proportion
of US-based dentists had either never attended a CE
course on oral cancer or had done so years ago
[35,39,40]. The recency of oral cancer CE attendance is
important because studies have found it to be positively
associated with measures [37,39] and perceptions of cur-
rent oral cancer knowledge [36] and possibly, the thor-
oughness of the oral cancer examination [39]. While
oral cancer CE received mixed reviews among the study
KIs, it is notable that one participant who had attended
such CE reported changing clinical practice by including
a tactile component in the oral cancer examination. It is
also notable that one respondent called for oral cancer
CE to be required for relicensure of all Puerto Rico
healthcare professionals, a recommendation voiced in a
previous US report [37].
Oral Cancer Examinations
Studies conducted in the US have found that dentists
are more likely than physicians to report performing
opportunistic oral cancer examinations [31,41], and as
in previous investigations [27,42], there was broad
agreement among the study participants that dentists
have the major responsibility for providing such exami-
nations. It is noteworthy however, that a subset of the
KIs felt that such examinations should be routinely pro-
vided by other health professionals as well.
Most, but not all, of the KIs reported at least some
training in performing oral cancer screenings, and as
with previous reports, lack of training was a contribut-
ing factor for failing to conduct oral cancer examina-
tions [27,38,40]. To highlight the importance of such
examinations, it has been suggested that dental schools
require their students to demonstrate competency in
performing oral cancer examinations [38], and such a
proficiency may have utility at the Puerto Rico Schools
of Medicine and Dental Medicine. As stated above, it
also appears prudent that medical and dental applicants
for licensure in Puerto Rico be required to demonstrate
proficiency in performing an oral cancer examination.
In keeping with previous reports [38-40,43,44], the
participants indicated that their current conduct of
opportunistic oral cancer screenings is often limited in
terms of the elements included in the examination and
the patients who receive them. Although visual oral
examinations have reported utility in increasing the
detection of early-stage oral cancers [45] and in redu-
cing the risk of oral cancer mortality in tobacco or alco-
hol users [46], it has long been advocated that oral
examinations screening for cancer and precancer should
incorporate both a visual and tactile component, which
includes palpation of cervical lymph nodes and the
major salivary glands [47-53]. However, many participat-
ing KIs limited their oral cancer examinations to visual
inspections. Further, although it has been advocated that
all adult patients, and not just those at elevated risk, be
opportunistically screened for oral cancer and precancer,
at least in the dental setting [48], many KIs indicated
that they routinely provide an oral cancer examination
only for persons with characteristics that place them at
“high-risk.”
The observation that many Puerto Rico practitioners
are limiting their opportunistic oral cancer screening
examinations, both in terms of which patients receive an
examination and which, if any, sites are palpated, is con-
sistent with reports from previous investigations in other
geographic regions [38-40]. Of note, in one US-based
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cians in their training to perform a visual oral cancer
examination while physicians were more confident than
dentists in palpating cervical lymph nodes [54].
Apart from training, variation in oral cancer examina-
tion practices may result, at least in part, from the lack
of definitive consensus-generated guidelines that specifi-
cally state which patients should be examined, which
elements should be included in a routine oral cancer
examination, and how often such examinations should
be performed in asymptomatic patients [38,49,55].
Further, statements reading, for example, “there is insuf-
ficient evidence to support or refute the use of a visual
examination as a method of screening for oral cancer”
[56] can easily be misinterpreted as stating that opportu-
nistic visual oral cancer examinations have no value. A
recent report from an expert panel convened by the
American Dental Association to evaluate current evi-
dence regarding the possible risks and benefits of oral
cancer screening addressed some of the above issues by
recommending that “clinicians remain alert for signs of
potential malignant lesions or early-stage cancers while
performing routine visual and tactile examinations in all
dental patients, but particularly those who use tobacco
or consume alcohol heavily” [8].
Biopsy
The current gold standard for diagnosing oral cancer
and precancer is a scalpel or punch biopsy followed by a
histopathologic diagnosis [4,5,8,9,57]. Based upon our KI
interviews, it appears that in Puerto Rico, most oral
biopsies are performed by oral and maxillofacial sur-
geons and ENTs, with other dental and medical practi-
tioners generally referring to those specialists. Surveys in
various other regions of the world have also found that
most patients requiring an oral biopsy are referred to
specialists [58-61].
Some participating KIs believed that general dentists
and perhaps primary care physicians should receive
additional training in performing biopsies, a practice
that could reduce professional-, system-, and/or patient-
based delays in the diagnosis of oral abnormalities.
Reports from areas outside Puerto Rico have reflected
the same sentiment, particularly with regard to biopsy-
ing apparently benign lesions. Others, however, have
voiced concerns that lack of expertise on the part of
some general practitioners may result in inappropriate
or inadequate biopsies as well as a disruption in the
clinical presentation of suspicious lesions, thereby lead-
ing to delays in the definitive diagnosis of oral precan-
cers and cancers [58]. Further, some general
practitioners may excise a lesion but lack sufficient
knowledge in terms of appropriate patient management
when a histopathologic diagnosis is received [59]. These
concerns argue against many general dentists and
primary care physicians biopsying lesions suspicious for
oral precancer/cancer and highlight the potential bene-
fits in having such procedures performed by practi-
tioners with advanced training whenever possible. If the
current standard of care for lesion biopsy among general
dentists and primary care physicians in Puerto Rico is
referral to a specialist, it is imperative that practitioners
be familiar not only with requirements put forth by
insurance entities, including GHSI, but also the impor-
tance of making an appropriate referral.
In the United States and for many cancers, health
insurance status is a significant predictor of stage at
diagnosis, with a higher likelihood of advanced stage dis-
ease for persons with either Medicaid or no health
insurance coverage relative to those with private insur-
ance [62,63]. In our interviews, Government-subsidized
health insurance (Reforma) was consistently cited as
problematic in the timely provision of oral biopsies
although other health insurance plans requiring pre-
authorizations prior to biopsy were also identified. The
situation with regard to Reforma is exacerbated by a) a
lack of information on the part of many patients and
practitioners regarding the basic provisions of GSHI, b)
a perceived financial disincentive on the part of primary
care physicians for referring Reforma patients to specia-
lists for oral biopsies, and c) diagnostic delays related to
sometimes time-consuming bureaucratic GSHI authori-
zations. These and other issues associated with health-
care under GSHI have received detailed attention in
previous comprehensive reports [23,24].
Study Limitations
The findings of the current qualitative investigation
should be considered in light of study limitations. We
elected to include a spectrum of healthcare practitioners
who, given their type of practice, could be involved in
the detection of oral precancer and early cancer. We
also chose to limit our focus to clinicians who practiced
in the Greater San Juan Metropolitan Area where the
majority of oral health services are concentrated in
Puerto Rico. Had we included a greater number of
healthcare specialists under each of the practice type
headings or interviewed healthcare professionals practi-
cing in other areas of Puerto Rico, we may have
obtained additional perspectives on the observed deficit
in oral precancer and early cancer identification. Never-
theless, those professionals who did participate were
consistent in their viewpoints across the spectrum of
practitioner type, and saturation was reached quickly.
We did not ask the study participants about high risk
human papillomavirus (HPV), a relatively recently
recognized risk factor for primarily squamous cell carci-
nomas of the oropharynx [64], nor did any of the key
informants bring up the topic. It is noteworthy that
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head and neck cancer, individuals who have an HPV-
positive head and neck cancer are more likely to be
nondrinkers, nonsmokers, younger at the time of diag-
nosis and as likely to be female as male [65,66]. The dis-
parate profiles of persons with HPV-positive versus
those with HPV-negative head and neck tumors have
the potential to redefine how clinicians classify their
patients in terms of “high risk” and how they examine
them for oral and oropharyngeal cancer.
Conclusions
Based upon our interviews with clinicians practicing in
San Juan and consistent with other data sources, a num-
ber of practitioner-based factors were identified as likely
contributing to the deficit in oral precancer and early
cancer diagnosis on the island of Puerto Rico, as follows:
- Many healthcare professionals, including general
dentists, have a limited background knowledge of oral
cancer, which can arise from decrements in professional
training, a lack of exposure to oral cancer continuing
education, and a disinterest on the part of some health-
care practitioners.
- Many practitioners limit their opportunistic oral can-
cer screening examinations, in terms of which, if any,
patients receive them and which elements are included
in the examination.
- Oral biopsies are most often performed by specia-
lists, and patient referrals can be delayed by a number
of factors. The most frequently mentioned issues cen-
tered on government-subsidized health insurance, and
identified concerns focused on a) a lack of practitioner
knowledge regarding basic requirements and provisions
of GSHI, b) PCP-perceived financial disincentives asso-
ciated with the referral of Reforma patients for oral
biopsies, and c) diagnostic delays related to GSHI “red
tape.”
With the caveat that clinicians practicing in other
areas of Puerto Rico may have contributed additional
explanations for the observed deficit in oral precancer
and early cancer identification, our KI interviews pro-
vide insight into the knowledge, attitudes/beliefs and
practices of healthcare practitioners whose clinical activ-
ities can result in the early detection of such lesions.
The implementation of strategies to address the above
issues may be useful in reducing the deficit in detecting
oral precancers and early oral cancers in Puerto Rico.
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